Demethoxymurrapanine, an indole‐naphthoquinone alkaloid, inhibits the proliferation of oral cancer cells without major side effects on normal cells

• Published in: Environmental toxicology Vol. 39; no. 3; pp. 1221 - 1234
• Main Authors: Chuang, Ya‐Ting, Yen, Ching‐Yu, Shiau, Jun‐Ping, Chang, Fang‐Rong, Duh, Chang‐Yih, Sung, Ping‐Jyun, Chen, Kuan‐Liang, Tsai, Yi‐Hong, Tang, Jen‐Yang, Jeng, Jiiang‐Huei, Sheu, Jyh‐Horng, Chang, Hsueh‐Wei
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.03.2024; Wiley Subscription Services, Inc
• Subjects: Acetylcysteine; Acetylcysteine - pharmacology; alkaloid; alkaloids; Alkaloids - pharmacology; Alkaloids - therapeutic use; Annexin V; Antioxidants; Antioxidants - pharmacology; Antiproliferatives; Apoptosis; Biological stress; Cancer; caspases; Cell Line, Tumor; Cell Proliferation; Cell viability; Cells; Cytotoxicity; Damage; Deoxyguanosine; Deoxyribonucleic acid; DNA; DNA Damage; ecotoxicology; Glutathione; Humans; Indoles - pharmacology; indole‐naphthoquinone; mitochondria; mouth neoplasms; Mouth Neoplasms - drug therapy; Murraya paniculata; Oral cancer; Oxidative Stress; Proliferation; Reactive Oxygen Species; Side effects; Murraya paniculata; indole-naphthoquinone; alkaloid; oral cancer; oxidative stress
• ISSN: 1520-4081; 1522-7278; 1522-7278
• DOI: 10.1002/tox.24002

Antioral cancer drugs need a greater antiproliferative impact on cancer than on normal cells. Demethoxymurrapanine (DEMU) inhibits proliferation in several cancer cells, but an in‐depth investigation was necessary. This study evaluated the proliferation‐modulating effects of DEMU, focusing on oral cancer and normal cells. DEMU (0, 2, 3, and 4 μg/mL) at 48 h treatments inhibited the proliferation of oral cancer cells (the cell viability (%) for Ca9‐22 cells was 100.0 ± 2.2, 75.4 ± 5.6, 26.0 ± 3.8, and 15.4 ± 1.4, and for CAL 27 cells was 100.0 ± 9.4, 77.2 ± 5.9, 57.4 ± 10.7, and 27.1 ± 1.1) more strongly than that of normal cells (the cell viability (%) for S‐G cells was 100.0 ± 6.6, 91.0 ± 4.6, 95.0 ± 2.6, and 95.8 ± 5.5), although this was blocked by the antioxidant N‐acetylcysteine. The presence of oxidative stress was evidenced by the increase of reactive oxygen species and mitochondrial superoxide and the downregulation of the cellular antioxidant glutathione in oral cancer cells, but these changes were minor in normal cells. DEMU also caused greater induction of the subG1 phase, extrinsic and intrinsic apoptosis (annexin V and caspases 3, 8, and 9), and DNA damage (γH2AX and 8‐hydroxy‐2‐deoxyguanosine) in oral cancer than in normal cells. N‐acetylcysteine attenuated all these DEMU‐induced changes. Together, these data demonstrate the preferential antiproliferative function of DEMU in oral cancer cells, with the preferential induction of oxidative stress, apoptosis, and DNA damage in these cancer cells, and low cytotoxicity toward normal cells.